Trials / Completed
CompletedNCT00317486
Effects of Tracleer (Bosentan) on Pulmonary Arterial Hypertension Related to Eisenmenger Physiology
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of Tracleer (Bosentan) on Oxygen Saturation and Cardiac Hemodynamics in Patients With Pulmonary Arterial Hypertension Related to Eisenmenger Physiology
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 54 (actual)
- Sponsor
- Actelion · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the effects of bosentan on oxygen saturation, hemodynamics and exercise capacity in patients with pulmonary arterial hypertension related to Eisenmenger physiology. Patients receive bosentan or placebo for 16 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | bosentan |
Timeline
- Start date
- 2003-09-01
- Primary completion
- 2005-04-01
- Completion
- 2005-04-01
- First posted
- 2006-04-25
- Last updated
- 2025-02-04
Source: ClinicalTrials.gov record NCT00317486. Inclusion in this directory is not an endorsement.